ASK REDCHAT ANYTHING ABOUT ACHIEVE LIFE SCIENCES INC.
Achieve Life Sciences Inc. (NASDAQ: ACHV)
Listen to this Section
$5.01
-0.2790
(
-5.27% )
299.0K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| CytisiniclineDetailsSmoking cessation |
Phase 3 |
Market Data
|
| Open |
$5.01 |
| Previous Close |
$5.29 |
| Volume |
299.0K |
| Market Cap |
$505.08M |
| Day Range |
$4.98 - $5.28 |
| 52 Week Range |
$2.00 - $6.15 |
| Shares Outstanding |
102.66M |
| Change % |
-5.27% |
| Net Change |
▼ -0.2790 |
| Insider Ownership |
-0.08% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| IPO Year | 1995 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-630,375.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-01-24 |
Sale |
-31500.00 |
HIMES VAUGHN B |
| 2024-01-24 |
Sale |
-31500.00 |
Sellig Thomas |
| 2024-01-24 |
Sale |
-31500.00 |
Duty Stuart |
| 2024-01-24 |
Sale |
-31500.00 |
KING THOMAS BRAXTON |
| 2024-01-24 |
Sale |
-84000.00 |
JACOBS CINDY |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 10-k |
Annual reports |
93 |
Mar 24, 2026 |
| s-8 |
Registration statements |
14 |
Mar 24, 2026 |
| 8-k |
8K-related |
11 |
Mar 24, 2026 |
| 4 |
Insider transactions |
1 |
Jan 30, 2026 |
| 4 |
Insider transactions |
1 |
Jan 30, 2026 |
| 4 |
Insider transactions |
1 |
Jan 30, 2026 |
| 4 |
Insider transactions |
1 |
Jan 30, 2026 |
| 4 |
Insider transactions |
1 |
Jan 30, 2026 |
| 4 |
Insider transactions |
1 |
Jan 30, 2026 |
| schedule |
Other |
1 |
Jan 29, 2026 |